|
Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV and Kaposi Sarcoma Drug Development Program
|
29-07-15 |
|
Mark Wainberg, Ph.D., Joins Cannabis Science's Scientific Advisory Board; Cannabis Science Presents Further Dimensions of CS-TATI-1 Discovery Platform at 8th IAS Conference on HIV Pathogenesis
|
23-07-15 |
|
Cannabis Science, Inc. Initiates the Scientific Validation of the Biological Impact of Cannabinoids in Order to Better Define the Therapeutic Mechanism of Action Using Biochemical, Cell, and Genetic Approaches
|
17-07-15 |
|
Cannabis Science Signs Research & Distribution Agreement for California and Announces Guidance for Its New Product Releases in California and International Cannabinoid Research Operations
|
16-07-15 |
|
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials
|
27-05-15 |
|
CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo'
|
19-05-15 |
|
Cannabis Science (CBIS) Accepted To Present at ICAR 2015
|
22-04-15 |
|
Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives
|
31-03-15 |
|
After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest
|
26-03-15 |
|
Cannabis Science (OTC PINK: CBIS) to Be a Featured Guest on "Your Money's Worth" National Radio Show, Tonight From 5-7 PM (EST) on 1470 AM, WWNN Radio South Florida, as Well as Live Internet Streaming
|
18-12-15 |
